Work in progress: serial evaluation of tumor volume using computed tomography and contrast kinetics.

Abstract

Computed tomography can be used to evaluate tumor volume changes after therapy. Pre- and posttreatment results are presented for nine human neoplasms. Volume changes are correlated with the behavior of intravenous diatrizoate contrast material. The five-minute diatrizoate distribution volume appears to be a potential contrast material marker for therapeutically induced tumor volume changes. Neoplasms decreasing in volume demonstrate a decrease in the diatrizoate distribution volume; those increasing in volume demonstrate an increase.

• Authors: D A Oppenheimer, S W Young, J B Marmor
• Journal: Radiology (Radiology) Vol. 147 Issue 2 Pg. 495-7 (May 1983) ISSN: 0033-8419 [Print] United States
• PMID: 6836128 (Publication Type: Comparative Study, Journal Article, Research Support, U.S. Gov't, P.H.S.)

Chemical References

• Diatrizoate
• Diatrizoate Meglumine

Topics

• Carcinoma, Squamous Cell (diagnostic imaging, therapy)
• Diatrizoate (analogs & derivatives)
• Diatrizoate Meglumine
• Evaluation Studies as Topic
• Humans
• Kinetics
• Melanoma (diagnostic imaging, therapy)
• Time Factors
• Tomography, X-Ray Computed